![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07D 263/57 | |
A61K 31/423 | |||
A61P 25/00 |
(11) | Number of the document | 3453703 |
(13) | Kind of document | T |
(96) | European patent application number | 17792508.8 |
Date of filing the European patent application | 2017-05-05 | |
(97) | Date of publication of the European application | 2019-03-13 |
(45) | Date of publication and mention of the grant of the patent | 2020-06-24 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/CN2017/083177 |
Date | 2017-05-05 |
(87) | Number | WO 2017/190682 |
Date | 2017-11-09 |
(30) | Number | Date | Country code |
201610293338 | 2016-05-05 | CN |
(72) |
CHEN, Minhua, CN
ZHANG, Yanfeng, CN
LI, Jiaoyang, CN
ZHANG, Xiaoyu, CN
|
(73) |
Crystal Pharmatech Co., Ltd,
B4-101 Biobay 218 Xinghu Street Suzhou Industrial Park, Suzhou, Jiangsu 215123,
CN
|
(54) | CRYSTALLINE FORM E OF TAFAMIDIS MEGLUMINE, PROCESS FOR PREPARATION AND USE THEREOF |
CRYSTALLINE FORM E OF TAFAMIDIS MEGLUMINE, PROCESS FOR PREPARATION AND USE THEREOF |